FUSION
associated with 3 other trademarks
Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payl...

Words that describe this trademark:

clinical research  drug discovery  material used  used drug  discovery pharmaceutical  pharmaceutical development  bifunctional  research  development  chelate 

Serial Number:

90447045

Mark:

FUSION

Status:

Registered

Status Date:

07-11-2023

Filing Date:

Registration Number:

7108424

Registration Date:

07-11-2023

Goods and Services:

Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to affected cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

09-13-2022

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

PIERCE ATWOOD LLP

Correspondent Name:

Recent Trademark filings by this company